MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC

Published:2012-09-13 Issue:3 Volume:27 Page:686-694
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Min D-J,Ezponda T,Kim M K,Will C M,Martinez-Garcia E,Popovic R,Basrur V,Elenitoba-Johnson K S,Licht J D

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2012269.pdf

Reference54 articles.

1. Bergsagel PL, Kuehl WM . Chromosome translocations in multiple myeloma. Oncogene 2001; 20: 5611–5622.

2. Dib A, Gabrea A, Glebov OK, Bergsagel PL, Kuehl WM . Characterization of MYC translocations in multiple myeloma cell lines. J Natl Cancer Inst Monogr 2008; 39: 25–31.

3. Chapman MA, Lawrence MS, Keats JJ, Cibulskis K, Sougnez C, Schinzel AC et al. Initial genome sequencing and analysis of multiple myeloma. Nature 2011; 471: 467–472.

4. Lin Y, Wong K, Calame K . Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. Science 1997; 276: 596–599.

5. Keats JJ, Reiman T, Maxwell CA, Taylor BJ, Larratt LM, Mant MJ et al. In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression. Blood 2003; 101: 1520–1529.

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. C-terminal binding protein 2 is a novel tumor suppressor targeting the MYC-IRF4 axis in multiple myeloma;Blood Advances;2024-04-29

2. Myeloma and DNA damage;Blood Journal;2023-11-22

3. Drug Discovery Targeting Nuclear Receptor Binding SET Domain Protein 2 (NSD2);Journal of Medicinal Chemistry;2023-08-14

4. Recent advances in nuclear receptor-binding SET domain 2 (NSD2) inhibitors: An update and perspectives;European Journal of Medicinal Chemistry;2023-03

5. Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myeloma;JCI Insight;2023-02-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3